Interventional Ablation for Early-stage Lung Cancer

Clinical trial NCT07005999 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07005999
Sponsor: Guangzhou Institute of Respiratory Disease
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Lung Cancer (NSCLC)Early Stage Lung Non-Small Cell Carcinoma

Start date: 2025-04-12
Primary completion: 2028-12-21
Enrollment: 656

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.